Savonix, a San Francisco, CA-based digital technology-driven neurocognitive testing company, raised $5.1m in Series A funding.
The round, which brought total financing to $6.6m, was led by DigiTx Partners with participation from Rethink Impact. In conjunction with the funding, Dr. David Kim, CEO at DigiTx Partners, and Heidi Patel, Partner at Rethink Impact, will join the Savonix Board of Directors.
The company intends to use the funds to scale its business to global markets including Japan and China, develop additional partnerships with medical organizations and invest in a data science and product team.
Founded in 2015 by CEO Dr. Mylea Charvat, Savonix provides Savonix Mobile, a mobile cognitive assessment platform that offers healthcare providers, payers and patients a comprehensive view into critical domains of cognitive function. Savonix Mobile enables clinicians to assess, track and understand a patient’s cognitive health and use that data to build better treatment plans based on an individual’s specific needs.